We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-5.94%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.24B
AUM Growth
-$312M
Cap. Flow
+$100M
Cap. Flow %
1.91%
Top 10 Hldgs %
19.63%
Holding
588
New
50
Increased
219
Reduced
167
Closed
31

Top Sells

Rank Stock Value
1
FL
Foot Locker
FL
+$42.5M
2
WMT icon
Walmart Inc
WMT
+$15.2M
3
JPM icon
JPMorgan Chase
JPM
+$14.9M
4
ENOV icon
Enovis
ENOV
+$14.8M
5
PH icon
Parker-Hannifin
PH
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Healthcare 18.75%
3 Consumer Discretionary 11.87%
4 Financials 9.73%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
426
American Tower
AMT
$79.8B
$544K 0.01%
2,167
+493
+29% +$120K
PFG icon
427
Principal Financial Group
PFG
$24.7B
$537K 0.01%
7,200
CTVA icon
428
Corteva
CTVA
$51.3B
$525K 0.01%
+9,000
New +$460K
KZR
429
DELISTED
Kezar Life Sciences
KZR
$524K 0.01%
+3,100
New +$445K
CINF icon
430
Cincinnati Financial
CINF
$27.5B
$511K 0.01%
3,700
AUTL
431
Autolus Therapeutics
AUTL
$532M
$508K 0.01%
120,000
LAUR icon
432
Laureate Education
LAUR
$5.14B
$504K 0.01%
41,186
-9,000
-18% -$109K
LGND icon
433
Ligand Pharmaceuticals
LGND
$6.02B
$500K 0.01%
6,893
ADPT icon
434
Adaptive Biotechnologies
ADPT
$3.75B
$495K 0.01%
35,700
VCYT icon
435
Veracyte
VCYT
$3.71B
$489K 0.01%
17,000
TDOC icon
436
Teladoc Health
TDOC
$1.21B
$486K 0.01%
6,649
+750
+13% +$54K
OCUL icon
437
Ocular Therapeutix
OCUL
$1.92B
$484K 0.01%
95,800
PBA icon
438
Pembina Pipeline
PBA
$27.9B
$469K 0.01%
12,400
PACB icon
439
Pacific Biosciences
PACB
$363M
$468K 0.01%
+48,500
New +$558K
EG icon
440
Everest Group
EG
$14.2B
$457K 0.01%
1,500
KYMR icon
441
Kymera Therapeutics
KYMR
$8.75B
$457K 0.01%
+11,000
New +$465K
TME icon
442
Tencent Music
TME
$15.7B
$448K 0.01%
90,000
ZNTL icon
443
Zentalis Pharmaceuticals
ZNTL
$356M
$447K 0.01%
9,800
RVMD icon
444
Revolution Medicines
RVMD
$42.1B
$445K 0.01%
17,400
GMAB icon
445
Genmab
GMAB
$18.3B
$442K 0.01%
12,000
AXSM icon
446
Axsome Therapeutics
AXSM
$10.8B
$440K 0.01%
11,000
HES
447
DELISTED
Hess
HES
$434K 0.01%
+4,000
New +$379K
RGNX icon
448
Regenxbio
RGNX
$722M
$430K 0.01%
13,000
CF icon
449
CF Industries
CF
$17.9B
$424K 0.01%
+4,200
New +$339K
GL icon
450
Globe Life
GL
$14.4B
$419K 0.01%
4,100

Similar funds

Erste Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Erste Asset Management held 588 positions worth $5.24B, down 5.6% from $5.55B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Erste Asset Management's Q1 2022 filing shows 50 new, 219 increased, 167 reduced and 31 closed positions. Its largest new stake was Houghton Mifflin Harcourt Company: 920,000 shares worth $19.3M. The largest sale was Foot Locker, an estimated $42.5M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q1 2022 buy was Houghton Mifflin Harcourt Company: 920,000 shares worth $19.3M.
  • Erste Asset Management added most to Pfizer in Q1 2022, an estimated $26.5M increase.
  • Erste Asset Management's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $15.2M.
  • Erste Asset Management fully exited Foot Locker in Q1 2022, selling an estimated $42.5M.
  • Erste Asset Management's ten largest holdings make up 20% of its $5.24B portfolio in Q1 2022.
  • Erste Asset Management opened 50 new positions and closed 31 in Q1 2022.
  • Erste Asset Management's portfolio value fell 5.6% quarter-over-quarter to $5.24B.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.